Colitis ulcerative
Not recruitingStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
- Disease:Colitis ulcerative
- Substances:–
Hungary- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary76 clinical trials in Bekescsaba, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies evaluate new combination therapies and interventions for reducing major cardiac events.
Several trials are investigating novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Comprehensive research into inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis. Multiple trials are evaluating new therapeutic approaches for moderate to severe cases.
Focus on long-term efficacy and safety of various treatment options for inflammatory bowel conditions.
Advanced research into dyslipidemia and hypertriglyceridemia, with trials examining new therapeutic approaches for managing blood lipid levels and associated conditions.
Studies aim to improve treatment options for patients with various metabolic disorders and associated cardiovascular risks.
Tell us about your condition – we search every trial in Europe and connect you with the right site.